Streptozotocin-induced diabetes selectively enhances antinociception mediated by δ1-but not δ2-opioid receptors
- 31 December 1994
- journal article
- Published by Elsevier in Life Sciences
- Vol. 55 (6) , PL121-PL126
- https://doi.org/10.1016/0024-3205(94)90062-0
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Paradoxical analgesia produced by naloxone in diabetic mice is attributable to supersensitivity of δ-opioid receptorsBrain Research, 1992
- Role of spleen or spleen products in the deficiency in morphine-induced analgesia in diabetic miceBrain Research, 1992
- Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by μ-opioid agonists, but not by δ- and κ-opioid agonistsBrain Research, 1992
- Cross-tolerance studies in the spinal cord of β-FNA-treated mice provides further evidence for delta opioid receptor subtypesLife Sciences, 1991
- Different μ receptor subtypes mediate spinal and supraspinal analgesia in miceEuropean Journal of Pharmacology, 1989
- The analgesic defect of C57BL/6J-bgJ/bgJ (beige-J; Chediak-Higashi syndrome) mice transmitted by adoptive transfer of spleen cells to normal littermatesLife Sciences, 1988
- C57BL/6J-bg J (beige) mice: Differential sensitivity in the tail flick test to centrally administered MU- and delta-opioid receptor agonistsLife Sciences, 1987
- Naloxonazine actions in vivoEuropean Journal of Pharmacology, 1986
- Minireview: Multiple MU opiate receptorsLife Sciences, 1986
- Opiate Analgesia: Evidence for Mediation by a Subpopulation of Opiate ReceptorsScience, 1980